October 1 update. Our PDGM and ICD-10 tools now use the FY2027 code set: 190 codes added, 30 deleted, and no existing code changed clinical group.

See what changed

ICD-10 · PDGM grouping

E88 Other and unspecified metabolic disorders

All 24 codes in the E88 family, with the PDGM clinical group, comorbidity subgroup and primary-position rule CMS assigns, read from the CMS grouper crosswalk v07.2.26 and the CDC FY2027 code file.

ICD-10-CM FY2027 · CMS grouper v07.2.26

Codes in family

24

Can lead a claim

22

Cannot lead a claim

2

What CMS assigns to E88

22 of the 24 codes group to MMTA - Other; 2 are assigned no clinical group. Comorbidity subgroups: 1 toward Obesity, and Disorders of Metabolism and Fluid Balance; 1 toward Other Combined Immunodeficiencies and Malnutrition, includes graft-versus-host-disease; 22 are assigned none. 22 of the 24 can lead a claim. CMS attaches a code-first note to 2 of the 24.

  • Obesity, and Disorders of Metabolism and Fluid Balance: counts toward the high comorbidity tier only in an interaction pair.
  • Other Combined Immunodeficiencies and Malnutrition, includes graft-versus-host-disease: can award the low comorbidity tier as a secondary diagnosis.

Code first

CMS grouper convention 4, on E88.14. Code first:

  • associated AIDS (B20)

CMS grouper convention 12, on E88.A. Code first:

  • underlying disease

Every code in E88

Descriptions are CDC’s FY2027 wording; where CMS’s grouper abbreviates one, its form is shown beneath.

CodeDescriptionPrimary positionClinical groupComorbidity subgroup
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified
E88.01Alpha-1-antitrypsin deficiencyCan lead a claimANone
E88.02Plasminogen deficiencyCan lead a claimANone
E88.09Other disorders of plasma-protein metabolism, not elsewhere classifiedCMS: Oth disorders of plasma-protein metabolism, NECCan lead a claimANone
E88.1 Lipodystrophy, not elsewhere classified
E88.10Lipodystrophy, unspecifiedCan lead a claimANone
E88.11Partial lipodystrophyCan lead a claimANone
E88.12Generalized lipodystrophyCan lead a claimANone
E88.13Localized lipodystrophyCan lead a claimANone
E88.14HIV-associated lipodystrophyCan lead a claim, code first appliesANone
E88.19Other lipodystrophy, not elsewhere classifiedCan lead a claimANone
E88.2Lipomatosis, not elsewhere classifiedCan lead a claimANone
E88.3Tumor lysis syndromeCan lead a claimANone
E88.4 Mitochondrial metabolism disorders
E88.40Mitochondrial metabolism disorder, unspecifiedCan lead a claimANone
E88.41MELAS syndromeCan lead a claimANone
E88.42MERRF syndromeCan lead a claimANone
E88.43Disorders of mitochondrial tRNA synthetasesCan lead a claimANone
E88.49Other mitochondrial metabolism disordersCan lead a claimANone
E88.8 Other specified metabolic disorders
E88.81 Metabolic syndrome and other insulin resistance
E88.810Metabolic syndromeCan lead a claimANone
E88.811Insulin resistance syndrome, Type ACan lead a claimANone
E88.818Other insulin resistanceCan lead a claimANone
E88.819Insulin resistance, unspecifiedCan lead a claimANone
E88.82Obesity due to disruption of MC4R pathwayCan lead a claimAObesity, and Disorders of Metabolism and Fluid Balance
E88.89Other specified metabolic disordersCan lead a claimANone
E88.9Metabolic disorder, unspecifiedCannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone
E88.AWasting disease (syndrome) due to underlying conditionCannot lead a claimUnacceptable principal diagnosis, code is not reportable as principal diagnosisNoneOther Combined Immunodeficiencies and Malnutrition, includes graft-versus-host-disease

Sources: CMS HH PPS Grouper Software v07.2.26, effective 2026-10-01, for the clinical group, comorbidity subgroup, code-first conventions and primary-position flags; CDC NCHS ICD-10-CM FY2027 code descriptions for the family title and code wording. This is the crosswalk Medicare runs a claim through. Grouping also depends on admission source, timing, the OASIS functional items and the rest of the diagnosis list.

The monthly home health regs digest

What CMS changed, what's due next, and what to do about it — one email a month, no fluff. Read the first issue